# Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure

> **NCT00833365** · NA · TERMINATED · sponsor: **University of Utah** · enrollment: 15 (actual)

## Conditions studied

- Patent Ductus Arteriosus
- Prematurity

## Interventions

- **DRUG:** Ibuprofen
- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT00833365
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Study drug not available
- **Last updated:** 2016-07-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00833365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00833365, "Early Versus Late Use of Ibuprofen for Patent Ductus Arteriosus (PDA) Closure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00833365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*